Equitable Trust Co. Sells 1,789 Shares of DaVita Inc. (NYSE:DVA)

Key Points

• Equitable Trust Co. reduced its stake in DaVita Inc. by 4.8%, now owning 35,317 shares after selling 1,789 shares, valued at approximately $5.4 million.
• DaVita's stock decreased by 4.2%, with current trading at $144.90, while the company has a market cap of $10.94 billion and reported earnings of $2.00 per share, surpassing expectations.
• Recent analyst updates show mixed positions on DaVita, with one sell, three holds, and two buy ratings, while the average target price is set at $167.40.

Equitable Trust Co. lowered its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 4.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,317 shares of the company's stock after selling 1,789 shares during the period. Equitable Trust Co.'s holdings in DaVita were worth $5,402,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the business. Invesco Ltd. boosted its stake in DaVita by 20.9% during the fourth quarter. Invesco Ltd. now owns 1,589,545 shares of the company's stock worth $237,716,000 after acquiring an additional 275,284 shares in the last quarter. Northern Trust Corp boosted its stake in DaVita by 12.5% during the fourth quarter. Northern Trust Corp now owns 740,774 shares of the company's stock worth $110,783,000 after acquiring an additional 82,326 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in DaVita by 14.0% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 466,046 shares of the company's stock worth $69,697,000 after acquiring an additional 57,386 shares in the last quarter. Deutsche Bank AG boosted its stake in DaVita by 35.2% during the fourth quarter. Deutsche Bank AG now owns 392,422 shares of the company's stock worth $58,687,000 after acquiring an additional 102,230 shares in the last quarter. Finally, Epoch Investment Partners Inc. bought a new stake in DaVita during the fourth quarter worth about $55,100,000. Institutional investors own 90.12% of the company's stock.

DaVita Stock Down 4.2%

Shares of DaVita stock opened at $144.90 on Friday. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.20 and a current ratio of 1.25. The stock has a market capitalization of $10.94 billion, a PE ratio of 14.36, a price-to-earnings-growth ratio of 1.04 and a beta of 1.11. DaVita Inc. has a 52-week low of $131.76 and a 52-week high of $179.60. The company has a 50-day simple moving average of $140.31 and a two-hundred day simple moving average of $148.42.

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings data on Monday, May 12th. The company reported $2.00 earnings per share for the quarter, beating the consensus estimate of $1.75 by $0.25. DaVita had a net margin of 6.63% and a return on equity of 176.11%. The firm had revenue of $3.22 billion during the quarter, compared to analysts' expectations of $3.22 billion. During the same period in the previous year, the company earned $2.26 earnings per share. The firm's quarterly revenue was up 5.0% on a year-over-year basis. On average, analysts anticipate that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Insider Buying and Selling at DaVita

In other news, insider James O. Hearty sold 2,351 shares of the business's stock in a transaction that occurred on Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total transaction of $352,650.00. Following the completion of the transaction, the insider directly owned 26,038 shares of the company's stock, valued at $3,905,700. The trade was a 8.28% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 2.00% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research firms recently commented on DVA. Truist Financial dropped their price objective on shares of DaVita from $170.00 to $164.00 and set a "hold" rating on the stock in a research note on Monday, May 19th. Wall Street Zen raised shares of DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company's stock. According to MarketBeat, DaVita has an average rating of "Hold" and a consensus price target of $167.40.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.